GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 25 filers reported holding GAIN THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.73 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 90,000 | $403 | 0.39% |
| Greenlight Capital | 546,560 | $2,448,589 | 0.12% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 58,100 | $260,288 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 46,100 | $206,528 | 0.01% |
| NewEdge Advisors, LLC | 11,050 | $49,504 | 0.00% |
| Tower Research Capital LLC (TRC) | 4,347 | $19,475 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 12,562 | $56,278 | 0.00% |
| Citadel Advisors | 16,900 | $75,712 | 0.00% |
| Citadel Advisors | 36,247 | $162,387 | 0.00% |
| MORGAN STANLEY | 800 | $3,584 | 0.00% |